COCHLEAR LTD/ AU000000COH5 /
2024-06-14 9:43:48 PM | Chg. -1.100 | Volume | Bid9:59:56 PM | Ask9:59:56 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
200.450EUR | -0.55% | - Turnover: - |
199.540Bid Size: 13 | 200.900Ask Size: 13 | 13.16 bill.EUR | - | - |
GlobeNewswire
06-11
Envoy Medical Announces Addition of Medical Device Manufacturing Experience to its Board of Director...
GlobeNewswire
06-05
Newly Published Peer-Reviewed Article Highlights Advances in Fully Implanted Cochlear Implant Techno...
GlobeNewswire
05-14
Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
05-08
Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound G...
GlobeNewswire
04-03
Envoy Medical to Participate in the LD Micro Invitational XIV Conference April 8 - 9, 2024
GlobeNewswire
03-21
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Busi...
GlobeNewswire
03-20
ACELYRIN, INC. Announces Positive Phase 1/2 Proof-of-Concept Data for Lonigutamab, First Subcutaneou...
GlobeNewswire
03-04
Envoy Medical Secures Up To $10 Million Term Debt Financing to Advance Upcoming Clinical Trial
GlobeNewswire
02-29
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 20...
GlobeNewswire
02-07
Newly Introduced Bipartisan Bill Seeks to Clarify Fully Implanted Active Middle Ear Hearing Devices ...
GlobeNewswire
02-05
Envoy Medical CEO Brent Lucas Interviewed by Leading Healthcare Podcast Medical Alley
GlobeNewswire
01-22
Envoy Medical Announces Three Additional Patents for Implantable Cochlear Systems
GlobeNewswire
2023-11-20
Envoy Medical Provides Third Quarter 2023 Financial Results and Business Update
GlobeNewswire
2023-11-10
Envoy Medical Announces Publication of Additional Patent for Implantable Cochlear Systems
GlobeNewswire
2023-11-10
Altamira Therapeutics Announces European Patent Office Decision to Grant for Patent Application Cove...
GlobeNewswire
2023-11-06
Fennec Pharmaceuticals Announces Third Quarter 2023 Financial Results and Provides Business Update